Therapy sequencing strategies in multiple myeloma: who, what and why?

Future Oncol. 2018 Jan;14(2):95-99. doi: 10.2217/fon-2017-0493. Epub 2017 Dec 8.
No abstract available

Keywords: drug sequencing; multiple myeloma; novel therapy.

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boron Compounds / therapeutic use
  • Glycine / analogs & derivatives
  • Glycine / therapeutic use
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Indoles / therapeutic use
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / epidemiology
  • Multiple Myeloma / pathology
  • Oligopeptides / therapeutic use
  • Panobinostat
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Boron Compounds
  • Hydroxamic Acids
  • Indoles
  • Oligopeptides
  • elotuzumab
  • daratumumab
  • Thalidomide
  • ixazomib
  • carfilzomib
  • Panobinostat
  • pomalidomide
  • Glycine